绝经后2型糖尿病肾病患者炎症因子与骨密度的相关性
Correlation between Inflammatory Factors and Bone Mineral Density in Postmenopausal Patients with Type 2 Diabetic Nephropathy
DOI: 10.12677/ACM.2022.121081, PDF,   
作者: 于 洁:青岛市即墨区田横岛省级旅游度假区卫生院,山东 青岛;于婷婷:青岛市即墨区人民医院,山东 青岛;张雪娟:青岛大学附属医院,山东 青岛
关键词: 炎症因子骨质疏松2型糖尿病Inflammatory Factors Osteoporosis Type 2 Diabetes
摘要: 目的:探讨绝经后2型糖尿病肾病患者血清炎症因子水平与骨密度的相关性。方法:选择50例2019年1月至2021年3月以来于我院就诊的绝经后2型糖尿病肾病患者,收集患者的一般临床资料和炎症因子等指标进行相关性分析。结果:绝经后2型糖尿病肾病患者骨密度与CRP、TNF-α、IL-6呈负相关(r值分别为−0.284、−0.174、−0.097,均P < 0.05),而与IL-1β、IL-18无明显相关性。结论:本研究表明绝经后2型糖尿病肾病患者炎症因子水平与骨密度密切相关。
Abstract: Objective: To investigate the correlation between serum inflammatory factors and bone mineral density in postmenopausal patients with type 2 diabetic nephropathy. Methods: A total of 50 postmenopausal patients with type 2 diabetic nephropathy admitted to our hospital from January 2019 to March 2021 were selected, and their general clinical data and inflammatory factors and other indicators were collected for correlation analysis. Results: BMD was negatively correlated with CRP, TNF-α and IL-6 in postmenopausal patients with type 2 diabetic nephropathy (r = −0.284, −0.174, −0.097, all P < 0.05), but not with IL-1β and IL-18. Conclusions: This study indicates that the levels of inflammatory factors are closely related to bone mineral density in postmenopausal patients with type 2 diabetic nephropathy.
文章引用:于洁, 于婷婷, 张雪娟. 绝经后2型糖尿病肾病患者炎症因子与骨密度的相关性[J]. 临床医学进展, 2022, 12(1): 549-553. https://doi.org/10.12677/ACM.2022.121081

参考文献

[1] Schacter, G.I. and Leslie, W.D. (2017) Diabetes and Bone Disease. Endocrinology & Metabolism Clinics of North America, 46, 63-85.
[2] Song, K.H., Jeong, J.S., Kim, M.K., et al. (2019) Discordance in Risk Factors for the Progression of Diabetic Retinopathy and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus. Journal of Diabetes Investigation, 10, 745-752. [Google Scholar] [CrossRef] [PubMed]
[3] Raška Jr, I., Rasková, M., Zikán, V., et al. (2017) Prevalence and Risk Factors of Osteoporosis in Postmenopausal Women with Type 2 Diabetes Mellitus. Central European Journal of Public Health, 25, 3-10. [Google Scholar] [CrossRef] [PubMed]
[4] 苏木珍. 2型糖尿病肾病与无肾病患者骨密度及血清PTH变化随机对照研究[J]. 白求恩医学杂志, 2017, 15(2): 192-193.
[5] Patsch, J.M., Burghardt, A.J., Yap, S.P., et al. (2013) Increased Cortical Porosity in Type 2 Diabetic Postmenopausal Women with Fragility Fractures. Journal of Bone and Mineral Research, 28, 313-324. [Google Scholar] [CrossRef] [PubMed]
[6] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中华糖尿病杂志, 2021, 13(4): 95.
[7] 中华医学会糖尿病学分会微血管并发症学组. 中国糖尿病肾脏病防治指南(2021年版) [J]. 国际内分泌代谢杂志, 2021, 41(4): 23.
[8] 中华医学会. 原发性骨质疏松症基层诊疗指南(2019年) [J]. 中华全科医师杂志, 2020, 19(4): 304-315.
[9] Montagnani, A., Gonnelli, S., Alessandri, M. and Nuti, R. (2011) Osteoporosis and Risk of Fracture in Patients with Diabetes: An Update. Aging Clinical & Experimental Research, 23, 84-90. [Google Scholar] [CrossRef
[10] Thomas, M.C., Brownlee, M., Susztak, K., et al. (2015) Diabetic Kidney Disease. Nature Reviews Disease Primers, 1, 15018. [Google Scholar] [CrossRef] [PubMed]
[11] Narimiya, T., Kanzaki, H., Yamaguchi, Y., et al. (2019) Nrf2 Activation in Osteoblasts Suppresses Osteoclastogenesis via Inhibiting IL-6 Expression. Bone Reports, 11, Article ID: 100228. [Google Scholar] [CrossRef] [PubMed]
[12] Manolagas, S.C. (2010) From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis. Endocrine Reviews, 31, 266-300. [Google Scholar] [CrossRef] [PubMed]
[13] Ahmadi-Abhari, S., Luben, R.N., Wareham, N.J., et al. (2013) C-Reactive Protein and Fracture Risk: European Prospective Investigation into Cancer Norfolk Study. Bone, 56, 67-72. [Google Scholar] [CrossRef] [PubMed]
[14] Richards, J.B., Valdes, A.M., Burling, K., et al. (2007) Serum Adiponectin and Bone Mineral Density in Women. The Journal of Clinical Endocrinology & Metabolism, 92, 1517-1523. [Google Scholar] [CrossRef] [PubMed]